MILLISERT

Serial Number 86593767
606

Registration Progress

Application Filed
Apr 10, 2015
Under Examination
Nov 3, 2015
Approved for Publication
Sep 8, 2015
Published for Opposition
Sep 8, 2015
Registered

Trademark Image

MILLISERT

Basic Information

Serial Number
86593767
Filing Date
April 10, 2015
Published for Opposition
September 8, 2015
Abandonment Date
June 4, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 4, 2018
Classes
005 010

Rights Holder

EYEPOINT PHARMACEUTICALS US, INC.

03
Address
480 PLEASANT STREET, SUITE B300
WATERTOWN, MA 02472

Ownership History

pSivida US, Inc.

Original Applicant
03
Watertown, MA

pSivida US, Inc.

Owner at Publication
03
Watertown, MA

EYEPOINT PHARMACEUTICALS US, INC.

New Owner After Publication #1
03
WATERTOWN, MA

Legal Representation

Attorney
Jenevieve Maerker, Esq.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

36 events
Date Code Type Description Documents
Jun 4, 2018 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 4, 2018 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Apr 18, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 7, 2017 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 7, 2017 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 3, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 1, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 1, 2017 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 1, 2017 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 21, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 19, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 19, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 19, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 18, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 17, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 17, 2016 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 2, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 2, 2016 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 16, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 14, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 14, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 3, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 8, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 8, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 19, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 1, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 31, 2015 ALIE A ASSIGNED TO LIE Loading...
Jul 20, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 20, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 20, 2015 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 20, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 20, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 20, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 20, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 14, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Sustained drug delivery systems for ocular drugs
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 010